BioPharm Insight is your definitive guide to the global biopharma community, enabling clients to develop competitive strategies and capitalize on ideal business development opportunities with proprietary intelligence, real-time market analytics and a directory of key industry contacts.

Understand Your Industry

With an intuitive online user interface, detailed profiles, custom segment searches, real-time alerts and unrivaled personal support, BioPharm Insight enables you to become an active participant in how the global biopharma industry is shaped.

• Daily forward-looking intelligence updates from investigative journalists (view articles)
• 500,000 management and R&D contacts
• 7,500 biopharma companies
• 40,000 investigational drug programs
• 200,000 approved drugs
• 15,000 M&A and licensing deals
• 7,000 drug sales forecasts
• Detailed epidemiology profiles for every therapeutic area

Be an Active Participant

Featuring Active Intel, subscribers receive exclusive access to real-time coverage of critical events within the biopharma industry, including product development updates, CRO activity, licensing deals, litigation events, potential mergers and acquisitons, patent expirations, regulatory issues and more. We interview subject matter experts every day to deliver insight into market-moving events 6-12 months before mainstream media.

Begin a Conversation

Contact us to capitalize on your business development efforts.